Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIS correlation in sedation: remimazolam vs propofol in colonoscopic polypectomy
ChiCTR2200062413Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and propofol in colonic polyp (2 arms), sponsored by Tongji Hospital. Primary endpoints: Bispectral index (BIS), EMG signal and 1 more. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
colonic polyp
Beyond the preview
Go deeper on ChiCTR2200062413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062413.